CPT2 and myopathy: Of the 9899 genes whose expression was altered by at least 1 RID, CPT2 (carnitine palmitoyltransferase II) was in the top 1% of most commonly perturbed genes by this group of drugs.78CPT2 mutations have previously been associated with lipid lowering therapy-associated myopathy,79 but this finding highlights its potential importance, prioritizing it for further study.